Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125510971 | 12551097 | 1 | I | 201511 | 20160708 | 20160713 | 20160713 | PER | PHEH2016US017162 | NOVARTIS | 51.97 | YR | F | Y | 0.00000 | 20160713 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125510971 | 12551097 | 1 | PS | FEMARA | LETROZOLE | 1 | Unknown | 2.5 MG, QD | N | 20726 | 2.5 | MG | QD | ||||||
| 125510971 | 12551097 | 2 | SS | PALBOCICLIB | PALBOCICLIB | 1 | Oral | 125 MG, UNK, FOR 21 DAYS AND THEN HOLD FOR 7 DAYS | 0 | 125 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125510971 | 12551097 | 1 | Breast cancer |
| 125510971 | 12551097 | 2 | Breast cancer |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125510971 | 12551097 | Back pain | |
| 125510971 | 12551097 | Cough | |
| 125510971 | 12551097 | Scab |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125510971 | 12551097 | 1 | 201508 | 20160703 | 0 | |
| 125510971 | 12551097 | 2 | 201508 | 0 |